Fred Hassan appointed Executive Chair of Norstella
New York, New York – Jan. 12, 2026 – Norstella, a leading global provider of pharma intelligence solutions, announced today that healthcare industry leader Fred Hassan has been appointed Executive Chair.
Norstella appoints Dan Tempesta as Chief Financial Officer
New York, New York – Sept. 9, 2025 – Norstella, a leading global provider of pharma intelligence solutions, has appointed Dan Tempesta as its new Chief Financial Officer. This marks an exciting milestone in Norstella’s journey and underscores the company’s commitment to its next phase of growth.
Panalgo revolutionizes real-world data with launch of LinQNotes and Ella AI
Boston, MA – May 14, 2025 – Panalgo, a Norstella company dedicated to revolutionizing healthcare analytics, today announced the launch of two game-changing solutions: LinQNotes and Ella AI. Together, these solutions mark a bold step forward in Panalgo’s mission to make insights more accessible, actionable, and immediate. Ella AI and LinQNotes combine the power of structured and unstructured data analysis to deliver a more complete view of the patient journey—from rapid cohort creation to rich clinical context.
Norstella named to Fast Company’s annual list of the world’s most innovative companies of 2025
New York – March 18, 2025 – Norstella, a leading global provider of pharma intelligence solutions, is proud to have been named to Fast Company’s prestigious list of the World’s Most Innovative Companies of 2025. This year’s list shines a spotlight on businesses that are shaping industry and culture through their innovations to set new standards and achieve remarkable milestones in all sectors of the economy.
Neelesh Sali named Managing Director & Country Head of Norstella India
New York – February 5, 2025 – Norstella, a leading global provider of pharma intelligence solutions, is proud to announce the appointment of Neelesh Sali as Managing Director and Country Head for India. With over 30 years of leadership experience driving operational excellence and scaling global organizations, Neelesh brings a proven track record of transformative growth and innovation to Norstella’s mission of smoothing the path to life-saving treatments.
NorstellaLinQ data source added to Atropos Evidence™ Network, scoring in the top decile for data quality on Real World Fitness Score®
Palo Alto, CA – February 4, 2025 – Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence (RWE) for care, announces the availability of an initial dataset from NorstellaLinQ on the Atropos Evidence Network. NorstellaLinQ, built by Norstella, one of the largest global pharma intelligence solution providers, is the first and only fully integrated data asset combining real-world data (RWD) and proprietary intelligence from the most trusted brands in the industry, paving the way for breakthroughs in drug development and commercialization.
NorstellaLinQ in the news
Since introducing NorstellaLinQ, biopharma’s first fully integrated data asset combining RWD and our wealth of proprietary information, we have been busily meeting with customers to explain how it can support their workflows. It is not only our pharma partners that have taken notice, but the trade media has also wanted to learn more. Suzanne Caruso, General Manager for Clinical & Regulatory at Norstella, met with reporters from STAT and Precision Medicine Online to explain.
Norstella recognized as company of the year in the 2024 BIG Awards for Business
Norstella is pleased to announce that the Business Intelligence Group has selected the company as a winner in its hotly contested “Company of the Year” category. This recognition, part of the broader 2024 BIG Awards for Business, celebrates those companies, products, and leaders making a significant impact by reshaping their industries and setting new standards for success. For Norstella, it signifies the considerable progress we are making against our mission to to smooth the path to lifesaving therapies for patients and providers.
Norstella introduces NorstellaLinQ, the biopharma industry’s first fully integrated data asset
NEW YORK – October 8, 2024 – Today, Norstella unveiled NorstellaLinQ, the biopharma industry’s first and only fully integrated data asset combining both real-world data (RWD) — including open and closed claims, lab results and structured and unstructured electronic medical records (EMR) — with Norstella’s proprietary forecasting, clinical, regulatory, payer, coverage and commercial intelligence data.
Panalgo introduces IHD Cloud, a transformative solution for RWE data and analytics centralization
Boston, MA – Sept. 5, 2024 – Panalgo, a Norstella company committed to revolutionizing healthcare data analytics, is announcing the launch of IHD Cloud, a cutting-edge solution that will transform how organizations manage and use real-world data (RWD) to generate real-world evidence (RWE). Powered by Amazon Web Services (AWS), IHD Cloud offers a scalable and flexible platform to centralize data and technology, driving meaningful and timely insights for any evidence generating organization.